Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Abstract of presentation in January

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon Dec 18, 2021 11:52pm

182 Views

Post# 34244270

RE:RE:RE:RE:RE:RE:RE:Abstract of presentation in January

Mouth,

I can show slides from the past where it said 7 patients and trial would be concluded in a year . That was 2019. If you believe everything management says on a slide ..... like dsu options are for new hirers..... then I got some swampland in Florida for you . 7 million options for Toleikis , 5 million for Sweatlow ... they granted themselves over 40 million options at the last AGM , diluted the float by 25 % .

MS

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China